ANAESTHESIA FOR HYPOTHYROID
PATIENT
MODERATOR-Dr.RAGHURAM
PROFESSOR
DEPARTMENT OF ANAESTHESIA
PRESENTOR-Dr. S.SARAH SHAHNAZ
INTRODUCTION
THYROID GLAND
• Endocrine gland in the anterior and lateral
aspects of the neck
• Bi-lobed connected by the isthmus
• Upper border of isthmus is below the
cricoid cartilage
• Weighs about 20 grams
• Highly vascular gland-with rich capillary
permeation
• Recurrent laryngeal gland , external
laryngeal nerve are in close proximity to
the gland
• Innervated by adrenergic and cholinergic
nervous system
• The gland is made of follicles with
proteinaceous colloid
• Colloid has thyroglobulin-iodinated
glycoprotein-substrate for thyroid hormone
synthesis
• It bears parafollicular C cells-calcitonin
• The hypothalamo-pituitary-thyroid axis
plays an important role in body
metabolism
BLOOD SUPPLY OF THYROID GLAND
LYMPHATIC DRAINAGE
RELATIONAL ANATOMY
HYPOTHALAMO-PITUITARY-
THYROID AXIS
THYROID DISORDERS
• Hyperthyroidism
• Hypothyroidism
• Goitre-
single nodular
multinodular
• Thyroid tumors
follicular carcinoma
papillary carcinoma
medullary
carcinoma
anaplastic
carcinoma
parameter Values units
Serum TSH 0.5-5 micro units/ml
total T4 50-150 nanomol/litre
Total T3 1.5-3.5 nanomol/litre
Free T4 12-28 picomol/litre
freeT3 3-9 picomol/litre
thyroglobulin <1-35 micrograms/litre
HYPOTHYROIDISM
HYPOTHYROIDISM
• Relatively common in adult population
• Could be of two types
primary hypothyroidism
secondary hypothyroidism
euthyroid sick syndrome
Primary hypothyroidism
• Decreased production of thyroid hormones
inspite of adequate or increased levels of
TSH
seen most commonly
• TRH administration causes exaggerated TSH
elevation
Secondary hypothyroidism
• reduced levels of freeT4,T3,T4 and reduced
TSH level
• TRH stimulation confirms pituitary as cause
which shows absent or blunted reflex
Euthyroid sick syndrome
abnormal thyroid function tests in critically
ill patients with significant non thyroid illness
• Low level of T3 T4 and normal TSH level
• With deterioration of the disease,T3 and T4
level decreases further
• Stress induced as a physiological response
during surgery
• No treatment is needed
• Serum TSH
> 10milliunits/L implies hypothyroidism
<5 milliunits/L implies euthyroidism
ETIOLOGY
• Surgery-most common cause
• Radioactive iodine ablation
• Idiopathic
• Autoimmune
FEATURES OF HYPOTHYROIDISM
• Apathy
• Arthralgia
• Cardiac failure
• cardiomegaly
• Carpal tunnel syndrome
• Constipation
• Decreased sweating
• Deep hoarse voice
• Dry skin
• Intolerance to cold
• Impaired free water clearance-hyponatremia
• Lethargy
• Menorrhagia
• Non pitting edema
• Pleural and pericardial effusion
• Periorbital edema
• Sleep apnea
• Slow gastric emptying
• Slow mental functions
• Slow movement
• Weight gain –coarse facial features
-large tongue
TREATMENT
• Levothyroxine sodium commonly used
• Response to therapy
sodium and water diuresis
reduction in TSH level
• Patient with cardiomyopathy shows
measurable improvement in myocardial
function with therapy
• Angina if already present may worsen hence
angiogram is needed before hormone
replacement
HYPOTHYROIDISM AND
ANESTHESIA
HYPOTHYROIDISM AND ANAESTHSIA
• Mild to moderate thyroid dysfunction has
minimal impact peri-operatively
• Features expressed in hypothyroid state
directs the precautions to be taken peri-
operatively and intra-operatively
• Hypothyroidism reduces anaesthetic
requirement slightly
• Determination of medical treatment is
important
• Changes in thyroid function have been
documented in uncomplicated acute
myocardial infarction, congestive heart
failure, cardiopulmonary bypass.
• Significant T3 depression occurs which
may not get corrected with T3
administration
• Patient taking amiodarone are at risk of
hypothyroidism and needs a thyroid
function test before surgery
PREOPERATIVE PERIOD
• Euthyroid state is ideal for surgical
procedures
• For chronic thyroid disorder a preoperative
thyroid function test is needed
• Reliable report - if it is less than 6 months
• Thyroid stimulating hormone (TSH) is the
best to evaluate hypothyroidism
• Surgical stress may precipitate myxedema
or thyroid storm in untreated or severe
cases
• Elective surgeries must be postponed until
the patient is euthyroid
• Emergency surgeries must be done after
consultation with endocrinologist
• Chest x-ray or CT is used to rule out
tracheal or mediastinal involvement
• Continuation of drug on the day of surgery
is important
• In patients with no history of prior thyroid
dysfunction but with present history its
symptoms-TSH alone could be done
• Full replacement dose of levothyroxine-
1.6micrograms/kg/day
-elderly or those with coronary artery
disease the initial dose -25 µg daily
-increase every 2 to 6 weeks until
euthyroid state
• Half life of the drug is 7 days
INTRA-OPERATIVE PERIOD
• Increased risk when hypothyroid patient
goes through general or regional
anaesthesia
• Difficult intubation-Swollen oral cavity
-edematous vocal cords
-goitrous enlargement
• Aspiration risk and regurgitation risk-
decreased gastric emptying
Cardiovascular changes
• hypodynamic circulation
• Decreased cardiac output
• Decreased stroke volume
• Decreased heart rate
• Decreased baroreceptor reflexes
Respiratory changes
• Enhanced suppression of ventilatory
response to hypoxia and hypercarbia
Hematologic abnormalities
• Anemia 25%-50% of patients
• Platelet dysfunction and coagulation factor
abnormalities (factor viii)
• electrolyte imbalances-hyponatremia
Metabolic demands
• Hypoglycemia is common
• Hypothermia has quicker onset which is
difficult to treat
• decreased neuromuscular excitability
PRECAUTIONS
• Extremely sensitive to narcotics and
sedatives
-cautious pre operative sedation is needed
• Hypothyroidism effects on Minimum
Alveolar concentration is negligible
• Due to decreased hepatic metabolism and
renal excretion of drugs- induction agents
and neuromuscular blockers must be used
with caution
• Due to cardiovascular instability the
patient may need invasive monitoring and
transesophageal echocardiography
• In noncardiac surgery-intraoperative
hypotension occurs
• In cardiac surgery,heart failure was more
prevalent
GENERAL ANESTHESIA
• given through oral endotracheal tube
• Rapid sequence induction or awake
intubation done in case of difficult airway
• Inhalational agents may aggravate
myocardial depression
• Pancuronium is the ideal neuromuscular
blocker from cardiovascular standpoint but
careful dosing is needed due to reduced
skeletal muscle activity and reduced
hepatic metabolism
• Controlled ventilation needed as
spontaneous breathing may lead to
hypoventilation
• Intraoperative hypotension is managed by
pharmacological agents like
ephedrine,dopamine,epinephrine if
unresponsive may need supplemental
steroid administration
• Dextrose in normal saline is preferred to
avoid hypoglycemia and hyponatremia
POST OPERATIVE PERIOD
• Myxedema coma common in emergency
cases
• Intravenous thyroid replacement therapy
should be started
• intravenous L thyroxine takes 10 to12days
to yield peak basal metabolic rate
• Intravenous tri-iodothyronine effective in 6
hours with peak metabolic rate seen in 36
hours to 72 hours
• Levo thyroxine 300 to 500 mcg I.V or Levo tri-
iodothyronine 25 to 50 mcg I.V is the initial
dose
• Hypothyroidism may be associated with
decreased adrenal cortical function,steroid
coverage with hydrocortisone or
dexamethazone could be given
• Milrinone phosphodiesterase inhibitor may be
effective in the treatment of intraoperative
myocardial depression
• Post operatively ,if still no ability to administer
the drug enterally after 5 days, intravenous
(IV) levo thyroxine should be administered as
60% to 80% of the oral dose
• the hypothyroid group has a higher rate of
gastrointestinal and neuropsychiatric
complications post surgically
MYXEDEMA COMA
• Is a rare severe form of decompensated
hypothyroidism
• Mostly seen in elderly women with chronic
hypothyroidism
• Infection, trauma,cold and central nervous
system depressant predispose
hypothyroidism to myxedema coma
• Patient is not comatose but often needs
mechanical ventilation
• Hypothermia of less than 27 degree
centigrade is a cardinal feature with
impaired thermoregulation by
hypothyroidism
• Treatment of choice
Intravenous L-thyroxine or L-triiodothyronine
• Intravenous fluid-glucose containing saline
solution
• Thermoregulation
• Electrolyte imbalance correction
• Stabilization of cardiac and pulmonary
function
• Vitals-heart rate ,blood
pressure,temprature improve 24 hours
• Relative euthyroid is achieved in 3 to 5
days
• Hydrocortisone 100-300mcg/day is given
for adrenal insuffiency
• management in the intensive care unit
where proper ventilatory, electrolyte, and
hemodynamic support can be given.
• Passive rewarming, broad spectrum
antibiotic coverage and corticosteroids
may be needed.
• The definitive treatment is thyroid hormone
replacement administered as IV T4, 200 to
500 mcg as an initial bolus followed by 50-
100 mcg daily
• Few suggest addition of IV T3, 10-25 mcg
every 8 hours if available.
• Rapid thyroid hormone replacement may
precipitate myocardial infarction, hence
caution should be exercised in those with
underlying ischemic heart disease.
• Treatment of the precipitating cause like
an infection is critical for rapid recovery.
PREGNANCY AND HYPOTHYROIDISM
• Pregnancy is a state of excessive thyroid
stimulation
• increase in thyroid size by 10% in iodide
sufficient areas and 20-40% in iodide deficient
regions
• Due to physiological and hormonal changes
caused by pregnancy and human chorionic
gonadotropin (HCG) the production of
thyroxin (T4) and triiodothyronine (T3)
increase up to 50%
• 50% increase in daily iodide need, while
Thyroid-stimulating hormone (TSH) levels
are decreased in first trimester
• In an iodide sufficient area ,thyroid
adaptations during pregnancy are
tolerated, as stored inner iodide is
sufficient
• in iodide deficient areas, due to
physiological adaptations there are
significant changes during pregnancy
FEATURES
OVERT HYPOTHYROIDISM
• Abortion
• Anemia
• pregnancy-induced hypertension
• Preeclampsia
• premature birth
• low birth weight
• intrauterine fetal death
• increased neonatal respiratory distress
and
• infant neuro-developmental dysfunction
• placental abruption
• postpartum hemorrhage
SUBCLINICAL HYPOTHYROIDISM
• higher chance of placental abruption
• preterm birth
• miscarriage
• gestational hypertension
• fetal distress
• severe preeclampsia
• neonatal distress
• diabetes in pregnant women
• thyroid autoimmunity has effects similar to
that of subclinical hypothyroidism
• Subclinical hypothyroidism is the most
common thyroid dysfunction during
pregnancy
• hypothyroidism is very common during
pregnancy
• 2-3% of pregnant women suffer from
hypothyroidism
• 0.3-0.5% overt hypothyroidism and 2-2.5%
subclinical hypothyroidism
• main etiology for hypothyroidism in
pregnancy is iodide insufficiency
• in iodide sufficient areas, its main cause is
autoimmune thyroiditis
LABOUR COMPLICATION
• Labor – diskinetic,longer due to the
existence of the hypomyotonia and the
simultaneous cardio-respiratory problems;
hypokinesis
• Post-partum hemorrhages occur through
uterus hypotony and through coagulation
disorders
• Post-partum depression, post-partum
thyroiditis, hypogalactia
• Vitiated pelvis (limit pelvis) which can be
the reason of various cephalic-pelvis
disproportions
• Thyroid function test in pregnancy includes
free T3 and T4
• The free T4 index (FT4I) is an indirect
measure of FT4 and accounts for increase
in TBG.
• FT4I= TT4 ×RT3U
• The reported reference value for FT4I is
4.5-12.5mcg/dl.
• The values associated with hypothyroidism
increase in TSH
low FT4
low FT4I and
• variable presence of thyroperoxidase
antibodies (TPO)
• TSH and FT4/FT3 are used to assess and
follow thyroid diseases in pregnancy.
• limit of TSH should be
0.1 mIU/L -2.5 mIU/L in 1st trimester and
0.2 mIU/L -3mIU/L in 2nd and 3rd trimesters
• If the serum TSH is ≥3 mIU/L, tests are
repeated along with FT4 and TPO.
• Start levothyroxine meanwhile
• If declared euthyroid stop levothyroxine
• If TSH is >3mIU/L and FT4 is normal, then
patient should be tested throughout the
pregnancy
• If TSH >3mIU/L along with low FT4, then
levothyroxin is continued and the dose is
titrated to maintain TSH level in the range
of 0.5-2.5 mIU/ L
MEDICAL MANAGEMENT
• pre-existing hypothyroidism, there is 30-
50% increase in requirement of
levothyroxine during the first trimester.
• due to increased T4 metabolism, elevated
TBG as well as inhibition of thyroid
hormone (TH) absorption from the gut by
prenatal iron supplements.
• Could be treated by iron supplements and
TH four hours apart.
• hypothyroidism during pregnancy,
levothyroxine should be started at a dose
of 1-2 mcg/kg/day
• TSH levels should be reassessed 4-6
weeks following the dose change
• Treatment goal of TSH in the range of 0.5-
2.5 mIU/L.
• overt hypothyroidism diagnosed in
pregnancy, T4 should be normalised as
rapidly as possible by using two to three
times the estimated final daily dose.
ANESTHETIC MANAGEMENT
• During pre operative preparation, anxiolytics
and sedatives should be avoided
• administration of antihistamines like
ranitidine and oral sodium citrate solution
along with metoclopramide are considered
safe.
• Severe hypothyroidism should be managed
with IV T3/T4
• Hypothermia should be prevented in the
operation room as well as in the post
operative period
• hypothyroidism is associated with
qualitative platelet dysfunction-
dysfunction-arrangement of fresh frozen
plasma or platelets is needed
• epidural hematoma is a risk and presence
of normal coagulation should be confirmed
before regional anesthesia
• Vasopressor response is normal for
epinephrine but, decreased for
phenylephrine.
• During surgical stress, hydrocortisone
should be given
• Regional anesthesia should be favoured
over general anesthesia
• Nerve stimulators may not be useful
clinically due to abnormal response to the
peripheral nerve stimulator, due to
depression of neuromuscular junction
activities
REFERENCES
• Miller’s ANESTHESIA-volume1-eighth edition
• Stoelting’s anesthesia and co-existing disease-
second south asian edition
• MAEdiCA-a journal of clinical medicine-2010-
Maternal and fetal complications of the
hypothyroidism-related pregnancy
• Iran J Reprod Med-review article-2015-Thyroid
dysfunction and pregnancy outcomes
• Schwartz’s principles of surgery-10th edition
• https://www.apicareonline.com/thyroid-
disorders-during-pregnancy-and-anesthetic-
considerations/
Anaesthesia for hypothyroid patient

Anaesthesia for hypothyroid patient

  • 1.
  • 2.
  • 3.
    THYROID GLAND • Endocrinegland in the anterior and lateral aspects of the neck • Bi-lobed connected by the isthmus • Upper border of isthmus is below the cricoid cartilage • Weighs about 20 grams • Highly vascular gland-with rich capillary permeation • Recurrent laryngeal gland , external laryngeal nerve are in close proximity to the gland
  • 5.
    • Innervated byadrenergic and cholinergic nervous system • The gland is made of follicles with proteinaceous colloid • Colloid has thyroglobulin-iodinated glycoprotein-substrate for thyroid hormone synthesis • It bears parafollicular C cells-calcitonin • The hypothalamo-pituitary-thyroid axis plays an important role in body metabolism
  • 6.
    BLOOD SUPPLY OFTHYROID GLAND
  • 7.
  • 8.
  • 9.
  • 12.
    THYROID DISORDERS • Hyperthyroidism •Hypothyroidism • Goitre- single nodular multinodular • Thyroid tumors follicular carcinoma papillary carcinoma medullary carcinoma anaplastic carcinoma
  • 13.
    parameter Values units SerumTSH 0.5-5 micro units/ml total T4 50-150 nanomol/litre Total T3 1.5-3.5 nanomol/litre Free T4 12-28 picomol/litre freeT3 3-9 picomol/litre thyroglobulin <1-35 micrograms/litre
  • 14.
  • 15.
    HYPOTHYROIDISM • Relatively commonin adult population • Could be of two types primary hypothyroidism secondary hypothyroidism euthyroid sick syndrome
  • 17.
    Primary hypothyroidism • Decreasedproduction of thyroid hormones inspite of adequate or increased levels of TSH seen most commonly • TRH administration causes exaggerated TSH elevation Secondary hypothyroidism • reduced levels of freeT4,T3,T4 and reduced TSH level • TRH stimulation confirms pituitary as cause which shows absent or blunted reflex
  • 18.
    Euthyroid sick syndrome abnormalthyroid function tests in critically ill patients with significant non thyroid illness • Low level of T3 T4 and normal TSH level • With deterioration of the disease,T3 and T4 level decreases further • Stress induced as a physiological response during surgery • No treatment is needed • Serum TSH > 10milliunits/L implies hypothyroidism <5 milliunits/L implies euthyroidism
  • 19.
    ETIOLOGY • Surgery-most commoncause • Radioactive iodine ablation • Idiopathic • Autoimmune
  • 22.
    FEATURES OF HYPOTHYROIDISM •Apathy • Arthralgia • Cardiac failure • cardiomegaly • Carpal tunnel syndrome • Constipation • Decreased sweating
  • 23.
    • Deep hoarsevoice • Dry skin • Intolerance to cold • Impaired free water clearance-hyponatremia • Lethargy • Menorrhagia • Non pitting edema • Pleural and pericardial effusion • Periorbital edema
  • 24.
    • Sleep apnea •Slow gastric emptying • Slow mental functions • Slow movement • Weight gain –coarse facial features -large tongue
  • 28.
    TREATMENT • Levothyroxine sodiumcommonly used • Response to therapy sodium and water diuresis reduction in TSH level • Patient with cardiomyopathy shows measurable improvement in myocardial function with therapy • Angina if already present may worsen hence angiogram is needed before hormone replacement
  • 29.
  • 30.
    HYPOTHYROIDISM AND ANAESTHSIA •Mild to moderate thyroid dysfunction has minimal impact peri-operatively • Features expressed in hypothyroid state directs the precautions to be taken peri- operatively and intra-operatively • Hypothyroidism reduces anaesthetic requirement slightly • Determination of medical treatment is important
  • 31.
    • Changes inthyroid function have been documented in uncomplicated acute myocardial infarction, congestive heart failure, cardiopulmonary bypass. • Significant T3 depression occurs which may not get corrected with T3 administration • Patient taking amiodarone are at risk of hypothyroidism and needs a thyroid function test before surgery
  • 32.
    PREOPERATIVE PERIOD • Euthyroidstate is ideal for surgical procedures • For chronic thyroid disorder a preoperative thyroid function test is needed • Reliable report - if it is less than 6 months • Thyroid stimulating hormone (TSH) is the best to evaluate hypothyroidism • Surgical stress may precipitate myxedema or thyroid storm in untreated or severe cases
  • 33.
    • Elective surgeriesmust be postponed until the patient is euthyroid • Emergency surgeries must be done after consultation with endocrinologist • Chest x-ray or CT is used to rule out tracheal or mediastinal involvement • Continuation of drug on the day of surgery is important
  • 34.
    • In patientswith no history of prior thyroid dysfunction but with present history its symptoms-TSH alone could be done • Full replacement dose of levothyroxine- 1.6micrograms/kg/day -elderly or those with coronary artery disease the initial dose -25 µg daily -increase every 2 to 6 weeks until euthyroid state • Half life of the drug is 7 days
  • 35.
    INTRA-OPERATIVE PERIOD • Increasedrisk when hypothyroid patient goes through general or regional anaesthesia • Difficult intubation-Swollen oral cavity -edematous vocal cords -goitrous enlargement • Aspiration risk and regurgitation risk- decreased gastric emptying
  • 36.
    Cardiovascular changes • hypodynamiccirculation • Decreased cardiac output • Decreased stroke volume • Decreased heart rate • Decreased baroreceptor reflexes Respiratory changes • Enhanced suppression of ventilatory response to hypoxia and hypercarbia
  • 37.
    Hematologic abnormalities • Anemia25%-50% of patients • Platelet dysfunction and coagulation factor abnormalities (factor viii) • electrolyte imbalances-hyponatremia Metabolic demands • Hypoglycemia is common • Hypothermia has quicker onset which is difficult to treat • decreased neuromuscular excitability
  • 38.
    PRECAUTIONS • Extremely sensitiveto narcotics and sedatives -cautious pre operative sedation is needed • Hypothyroidism effects on Minimum Alveolar concentration is negligible • Due to decreased hepatic metabolism and renal excretion of drugs- induction agents and neuromuscular blockers must be used with caution
  • 39.
    • Due tocardiovascular instability the patient may need invasive monitoring and transesophageal echocardiography • In noncardiac surgery-intraoperative hypotension occurs • In cardiac surgery,heart failure was more prevalent
  • 40.
    GENERAL ANESTHESIA • giventhrough oral endotracheal tube • Rapid sequence induction or awake intubation done in case of difficult airway • Inhalational agents may aggravate myocardial depression • Pancuronium is the ideal neuromuscular blocker from cardiovascular standpoint but careful dosing is needed due to reduced skeletal muscle activity and reduced hepatic metabolism
  • 41.
    • Controlled ventilationneeded as spontaneous breathing may lead to hypoventilation • Intraoperative hypotension is managed by pharmacological agents like ephedrine,dopamine,epinephrine if unresponsive may need supplemental steroid administration • Dextrose in normal saline is preferred to avoid hypoglycemia and hyponatremia
  • 42.
    POST OPERATIVE PERIOD •Myxedema coma common in emergency cases • Intravenous thyroid replacement therapy should be started • intravenous L thyroxine takes 10 to12days to yield peak basal metabolic rate • Intravenous tri-iodothyronine effective in 6 hours with peak metabolic rate seen in 36 hours to 72 hours
  • 43.
    • Levo thyroxine300 to 500 mcg I.V or Levo tri- iodothyronine 25 to 50 mcg I.V is the initial dose • Hypothyroidism may be associated with decreased adrenal cortical function,steroid coverage with hydrocortisone or dexamethazone could be given • Milrinone phosphodiesterase inhibitor may be effective in the treatment of intraoperative myocardial depression
  • 44.
    • Post operatively,if still no ability to administer the drug enterally after 5 days, intravenous (IV) levo thyroxine should be administered as 60% to 80% of the oral dose • the hypothyroid group has a higher rate of gastrointestinal and neuropsychiatric complications post surgically
  • 45.
    MYXEDEMA COMA • Isa rare severe form of decompensated hypothyroidism • Mostly seen in elderly women with chronic hypothyroidism • Infection, trauma,cold and central nervous system depressant predispose hypothyroidism to myxedema coma • Patient is not comatose but often needs mechanical ventilation
  • 46.
    • Hypothermia ofless than 27 degree centigrade is a cardinal feature with impaired thermoregulation by hypothyroidism • Treatment of choice Intravenous L-thyroxine or L-triiodothyronine • Intravenous fluid-glucose containing saline solution • Thermoregulation • Electrolyte imbalance correction
  • 47.
    • Stabilization ofcardiac and pulmonary function • Vitals-heart rate ,blood pressure,temprature improve 24 hours • Relative euthyroid is achieved in 3 to 5 days • Hydrocortisone 100-300mcg/day is given for adrenal insuffiency
  • 48.
    • management inthe intensive care unit where proper ventilatory, electrolyte, and hemodynamic support can be given. • Passive rewarming, broad spectrum antibiotic coverage and corticosteroids may be needed. • The definitive treatment is thyroid hormone replacement administered as IV T4, 200 to 500 mcg as an initial bolus followed by 50- 100 mcg daily
  • 49.
    • Few suggestaddition of IV T3, 10-25 mcg every 8 hours if available. • Rapid thyroid hormone replacement may precipitate myocardial infarction, hence caution should be exercised in those with underlying ischemic heart disease. • Treatment of the precipitating cause like an infection is critical for rapid recovery.
  • 51.
  • 52.
    • Pregnancy isa state of excessive thyroid stimulation • increase in thyroid size by 10% in iodide sufficient areas and 20-40% in iodide deficient regions • Due to physiological and hormonal changes caused by pregnancy and human chorionic gonadotropin (HCG) the production of thyroxin (T4) and triiodothyronine (T3) increase up to 50%
  • 53.
    • 50% increasein daily iodide need, while Thyroid-stimulating hormone (TSH) levels are decreased in first trimester • In an iodide sufficient area ,thyroid adaptations during pregnancy are tolerated, as stored inner iodide is sufficient • in iodide deficient areas, due to physiological adaptations there are significant changes during pregnancy
  • 54.
    FEATURES OVERT HYPOTHYROIDISM • Abortion •Anemia • pregnancy-induced hypertension • Preeclampsia • premature birth • low birth weight • intrauterine fetal death
  • 55.
    • increased neonatalrespiratory distress and • infant neuro-developmental dysfunction • placental abruption • postpartum hemorrhage SUBCLINICAL HYPOTHYROIDISM • higher chance of placental abruption • preterm birth • miscarriage • gestational hypertension • fetal distress
  • 56.
    • severe preeclampsia •neonatal distress • diabetes in pregnant women • thyroid autoimmunity has effects similar to that of subclinical hypothyroidism • Subclinical hypothyroidism is the most common thyroid dysfunction during pregnancy
  • 57.
    • hypothyroidism isvery common during pregnancy • 2-3% of pregnant women suffer from hypothyroidism • 0.3-0.5% overt hypothyroidism and 2-2.5% subclinical hypothyroidism • main etiology for hypothyroidism in pregnancy is iodide insufficiency • in iodide sufficient areas, its main cause is autoimmune thyroiditis
  • 58.
    LABOUR COMPLICATION • Labor– diskinetic,longer due to the existence of the hypomyotonia and the simultaneous cardio-respiratory problems; hypokinesis • Post-partum hemorrhages occur through uterus hypotony and through coagulation disorders • Post-partum depression, post-partum thyroiditis, hypogalactia
  • 59.
    • Vitiated pelvis(limit pelvis) which can be the reason of various cephalic-pelvis disproportions • Thyroid function test in pregnancy includes free T3 and T4 • The free T4 index (FT4I) is an indirect measure of FT4 and accounts for increase in TBG. • FT4I= TT4 ×RT3U • The reported reference value for FT4I is 4.5-12.5mcg/dl.
  • 60.
    • The valuesassociated with hypothyroidism increase in TSH low FT4 low FT4I and • variable presence of thyroperoxidase antibodies (TPO) • TSH and FT4/FT3 are used to assess and follow thyroid diseases in pregnancy. • limit of TSH should be 0.1 mIU/L -2.5 mIU/L in 1st trimester and 0.2 mIU/L -3mIU/L in 2nd and 3rd trimesters
  • 61.
    • If theserum TSH is ≥3 mIU/L, tests are repeated along with FT4 and TPO. • Start levothyroxine meanwhile • If declared euthyroid stop levothyroxine • If TSH is >3mIU/L and FT4 is normal, then patient should be tested throughout the pregnancy • If TSH >3mIU/L along with low FT4, then levothyroxin is continued and the dose is titrated to maintain TSH level in the range of 0.5-2.5 mIU/ L
  • 63.
    MEDICAL MANAGEMENT • pre-existinghypothyroidism, there is 30- 50% increase in requirement of levothyroxine during the first trimester. • due to increased T4 metabolism, elevated TBG as well as inhibition of thyroid hormone (TH) absorption from the gut by prenatal iron supplements. • Could be treated by iron supplements and TH four hours apart.
  • 64.
    • hypothyroidism duringpregnancy, levothyroxine should be started at a dose of 1-2 mcg/kg/day • TSH levels should be reassessed 4-6 weeks following the dose change • Treatment goal of TSH in the range of 0.5- 2.5 mIU/L. • overt hypothyroidism diagnosed in pregnancy, T4 should be normalised as rapidly as possible by using two to three times the estimated final daily dose.
  • 65.
    ANESTHETIC MANAGEMENT • Duringpre operative preparation, anxiolytics and sedatives should be avoided • administration of antihistamines like ranitidine and oral sodium citrate solution along with metoclopramide are considered safe. • Severe hypothyroidism should be managed with IV T3/T4
  • 66.
    • Hypothermia shouldbe prevented in the operation room as well as in the post operative period • hypothyroidism is associated with qualitative platelet dysfunction- dysfunction-arrangement of fresh frozen plasma or platelets is needed • epidural hematoma is a risk and presence of normal coagulation should be confirmed before regional anesthesia
  • 67.
    • Vasopressor responseis normal for epinephrine but, decreased for phenylephrine. • During surgical stress, hydrocortisone should be given • Regional anesthesia should be favoured over general anesthesia • Nerve stimulators may not be useful clinically due to abnormal response to the peripheral nerve stimulator, due to depression of neuromuscular junction activities
  • 68.
    REFERENCES • Miller’s ANESTHESIA-volume1-eighthedition • Stoelting’s anesthesia and co-existing disease- second south asian edition • MAEdiCA-a journal of clinical medicine-2010- Maternal and fetal complications of the hypothyroidism-related pregnancy • Iran J Reprod Med-review article-2015-Thyroid dysfunction and pregnancy outcomes • Schwartz’s principles of surgery-10th edition • https://www.apicareonline.com/thyroid- disorders-during-pregnancy-and-anesthetic- considerations/